These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 9620062)
1. Glutamatergic regulation of striatal peptide gene expression in rats. Jolkkonen J; Jenner P; Marsden CD J Neural Transm Park Dis Dement Sect; 1995; 10(2-3):187-98. PubMed ID: 9620062 [TBL] [Abstract][Full Text] [Related]
2. Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis. Gerfen CR; McGinty JF; Young WS J Neurosci; 1991 Apr; 11(4):1016-31. PubMed ID: 1707092 [TBL] [Abstract][Full Text] [Related]
3. Acute methamphetamine-induced zif/268, preprodynorphin, and preproenkephalin mRNA expression in rat striatum depends on activation of NMDA and kainate/AMPA receptors. Wang JQ; McGinty JF Brain Res Bull; 1996; 39(6):349-57. PubMed ID: 9138744 [TBL] [Abstract][Full Text] [Related]
4. Chronic dizocilpine maleate (MK-801) treatment suppresses the effects of nigrostriatal dopamine deafferentation on enkephalin but not on substance P expression in the rat striatum. Hajji MD; Salin P; Kerkerian-Le Goff L Eur J Neurosci; 1996 May; 8(5):917-26. PubMed ID: 8743739 [TBL] [Abstract][Full Text] [Related]
5. N-methyl-D-aspartate receptor antagonism alters substance P and met5-enkephalin biosynthesis in neurons of the rat striatum. Somers DL; Beckstead RM J Pharmacol Exp Ther; 1992 Aug; 262(2):823-33. PubMed ID: 1380083 [TBL] [Abstract][Full Text] [Related]
6. Dopaminergic and muscarinic regulation of striatal enkephalin and substance P messenger RNAs following striatal dopamine denervation: effects of systemic and central administration of quinpirole and scopolamine. Nisenbaum LK; Kitai ST; Gerfen CR Neuroscience; 1994 Nov; 63(2):435-49. PubMed ID: 7534387 [TBL] [Abstract][Full Text] [Related]
7. GABAergic modulation of striatal peptide expression in rats and the alterations induced by dopamine antagonist treatment. Jolkkonen J; Jenner P; Marsden CD Neurosci Lett; 1994 Oct; 180(2):273-6. PubMed ID: 7535410 [TBL] [Abstract][Full Text] [Related]
8. 3-Nitropropionic acid toxicity in the striatum. Wüllner U; Young AB; Penney JB; Beal MF J Neurochem; 1994 Nov; 63(5):1772-81. PubMed ID: 7523600 [TBL] [Abstract][Full Text] [Related]
9. Striatal preprotachykinin and preproenkephalin mRNA levels and the levels of nigral substance P and pallidal Met5-enkephalin depend on corticostriatal axons that use the excitatory amino acid neurotransmitters aspartate and glutamate: quantitative radioimmunocytochemical and in situ hybridization evidence. Somers DL; Beckstead RM Brain Res Mol Brain Res; 1990 Jul; 8(2):143-58. PubMed ID: 1698246 [TBL] [Abstract][Full Text] [Related]
10. Partial striatal dopamine depletion differentially affects striatal substance P and enkephalin messenger RNA expression. Nisenbaum LK; Crowley WR; Kitai ST Brain Res Mol Brain Res; 1996 Apr; 37(1-2):209-16. PubMed ID: 8738153 [TBL] [Abstract][Full Text] [Related]
11. N-methyl-D-aspartate acutely increases proenkephalin mRNA in the rat striatum. Beckstead RM Synapse; 1995 Dec; 21(4):342-7. PubMed ID: 8869164 [TBL] [Abstract][Full Text] [Related]
12. Involvement of glutamate receptors in the striatal enkephalin-induced dopamine release. Dourmap N; Costentin J Eur J Pharmacol; 1994 Mar; 253(3):R9-11. PubMed ID: 8200414 [TBL] [Abstract][Full Text] [Related]
13. Temporal dissociation between changes in striatal enkephalin and substance P messenger RNAs following striatal dopamine depletion. Nisenbaum LK; Kitai ST; Crowley WR; Gerfen CR Neuroscience; 1994 Jun; 60(4):927-37. PubMed ID: 7523989 [TBL] [Abstract][Full Text] [Related]
14. Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum. Steiner H; Gerfen CR J Neurosci; 1993 Dec; 13(12):5066-81. PubMed ID: 7504719 [TBL] [Abstract][Full Text] [Related]
15. D1 dopamine receptor-mediated induction of zif268 and c-fos in the dopamine-depleted striatum: differential regulation and independence from NMDA receptors. Keefe KA; Gerfen CR J Comp Neurol; 1996 Apr; 367(2):165-76. PubMed ID: 8708002 [TBL] [Abstract][Full Text] [Related]
16. Metabotropic glutamate receptor agonist increases neuropeptide mRNA expression in rat striatum. Wang JQ; McGinty JF Brain Res Mol Brain Res; 1998 Mar; 54(2):262-9. PubMed ID: 9555048 [TBL] [Abstract][Full Text] [Related]
17. Differential regional effects of long-term L-DOPA treatment on preproenkephalin and preprotachykinin gene expression in the striatum of 6-hydroxydopamine-lesioned rat. Salin P; Dziewczapolski G; Gershanik OS; Nieoullon A; Raisman-Vozari R Brain Res Mol Brain Res; 1997 Jul; 47(1-2):311-21. PubMed ID: 9221930 [TBL] [Abstract][Full Text] [Related]
18. Localization of N-methyl-D-aspartate receptors in the rat striatum: effects of specific lesions on the [3H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid binding. Samuel D; Errami M; Nieoullon A J Neurochem; 1990 Jun; 54(6):1926-33. PubMed ID: 2159977 [TBL] [Abstract][Full Text] [Related]
19. Repeated injections of dizocilpine maleate (MK-801) do not suppress the effects of nigrostriatal dopamine deafferentation on glutamate decarboxylase (GAD67) mRNA expression in the adult rat striatum. Hajji MD; Salin P; Kerkerian-Le Goff L Brain Res Mol Brain Res; 1996 Dec; 43(1-2):219-24. PubMed ID: 9037536 [TBL] [Abstract][Full Text] [Related]
20. The muscarinic toxin 3 augments neuropeptide mRNA in rat striatum in vivo. Wang JQ; Jolkkonen M; McGinty JF Eur J Pharmacol; 1997 Sep; 334(1):43-7. PubMed ID: 9346326 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]